Skip to content
Home
Cynthia Jean Casaceli, M.B.A.

Cynthia Jean Casaceli, M.B.A.

Contact

Office (585) 276-3795
Administrative (585) 275-0553

Connect with Cynthia Jean Casaceli, M.B.A.

UR Neuroscience

About Me

Faculty Appointments

Research Associate Professor - Department of Neurology, Center for Health and Technology (SMD)

Credentials

Education

MBA | University of Rochester Simon School of Business. 1991

BS | State University of New York. Biochemistry. 1985

Publications

Journal Articles

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).

Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T

Parkinsonism & related disorders.. 2019 May 62 :201-209. Epub 01/31/2019.

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T,

Annals of clinical and translational neurology.. 2018 December 5 (12):1460-1477. Epub 10/31/2018.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD,

Clinical genitourinary cancer.. 2018 August 16 (4):e761-e769. Epub 02/05/2018.

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.

Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ,

Neurology.. 2017 December 1289 (24):2495-2502. Epub 11/15/2017.

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D,

Neurology.. 2017 November 789 (19):1959-1969. Epub 10/13/2017.

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).

Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB,

Movement disorders : official journal of the Movement Disorder Society.. 2016 January 31 (1):79-85. Epub 08/13/2015.

Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K,

Movement disorders : official journal of the Movement Disorder Society.. 2015 September 30 (10):1371-81. Epub 06/11/2015.

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.

Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE,

Investigative ophthalmology & visual science.. 2015 May 56 (5):3292-303. Epub 1900 01 01.

Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.

The Lancet. Neurology.. 2015 January 14 (1):39-47. Epub 11/14/2014.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS

Investigative ophthalmology & visual science.. 2014 November 455 (12):8180-8. Epub 11/04/2014.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M,

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.. 2014 June 34 (2):107-17. Epub 1900 01 01.

Association of cerebrospinal fluid ?-amyloid 1-42, T-tau, P-tau181, and ?-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligórska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM,

JAMA neurology.. 2013 October 70 (10):1277-87. Epub 1900 01 01.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T,

Annals of neurology.. 2012 March 71 (3):370-84. Epub 1900 01 01.

The Parkinson Progression Marker Initiative (PPMI).

Progress in neurobiology.. 2011 December 95 (4):629-35. Epub 09/14/2011.

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H,

PloS one.. 2011 6 (8):e22854. Epub 08/11/2011.

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I,

Movement disorders : official journal of the Movement Disorder Society.. 2009 December 1524 (16):2370-8. Epub 1900 01 01.

Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.

Miller RM, Kiser GL, Kaysser-Kranich T, Casaceli C, Colla E, Lee MK, Palaniappan C, Federoff HJ

Experimental neurology.. 2007 March 204 (1):421-32. Epub 01/24/2007.

Dysregulation of Gene Exppression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

Renee M. Miller; Linda M. Callahan; Cindy Casaceli; Linlin Chen, Gretchen L. Kiser; Buena Chui; Tamma M. Kaysser-Kranich; Timothy J. Sendera; Chockalingam Palaniappan; Howard J. Federoff.

JNEUROSCI. 2004; 4204-03.

Dementia consults: Predictors of compliance by primary care physicians.

Podgorski, C.A.; Lanning, B.D.; Casaceli, C.J.; Nardi, A.L.; Cox, C.

Am J of AD and Other Dementia. 2002; 17: 44-50.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read B,

Neurology.. 2001 February 2756 (4):455-62. Epub 1900 01 01.

Diagnostic accuracy of different ultrasonographic growth parameters in predicting discordancy in twin gestation: a different approach.

Shah YG, Sherer DM, Gragg LA, Casaceli CJ, Woods JR

American journal of perinatology.. 1994 May 11 (3):199-204. Epub 1900 01 01.

Ultrasonographic fetal weight estimation by an integrated computer-assisted system: can each laboratory improve its accuracy?

Thompson HO, Casaceli C, Woods JR

American journal of obstetrics and gynecology.. 1990 September 163 (3):986-95. Epub 1900 01 01.

Acute maternal morbidity following classical cesarean delivery of the preterm infant.

Shah YG, Ronner W, Eckl CJ, Stinson SK

Obstetrics and gynecology.. 1990 July 76 (1):16-9. Epub 1900 01 01.

Biparietal diameter/femur length ratio, cephalic index, and femur length measurements: not reliable screening techniques for Down syndrome.

Shah YG, Eckl CJ, Stinson SK, Woods JR

Obstetrics and gynecology.. 1990 February 75 (2):186-8. Epub 1900 01 01.